DEA Will Highlight Testimony On Marijuana’s Medical Benefits In Rescheduling Hearing, New Filing Shows
The DEA has filed a witness list for an upcoming cannabis rescheduling hearing that includes a physician who will testify about marijuana's medical benefits for pain patients, alongside an FDA official. This filing indicates the federal government's recognition of cannabis therapeutic applications in the rescheduling proceedings.
Filed under Federal Action in THC Minnesota's coverage of Minnesota's cannabis and hemp market.
Mentioned
Source Attribution
This summary was compiled from information published by Marijuana Moment. All facts and statements reflect the original source material. For complete details, refer to the original publication.
View Original Source →Related Updates
Marijuana Rescheduling Appeal Process ‘Remains Pending’ Despite Trump’s Executive Order, DEA Says In New Filing
Marijuana Rescheduling Could ‘Unlock Research’ To Treat Rare Diseases, Father Of Terminally Ill Child Tells Congressional Committee
Feds sued over Medicare cannabis product coverage (Newsletter: April 1, 2026)
Anti-Marijuana Groups File Lawsuit To Block Trump Administration’s Hemp CBD And THC Medicare Coverage Plan
Trump puts medical cannabis protections in budget (Newsletter: April 6, 2026)
Judge Rejects Anti-Marijuana Groups’ Motion To Block CBD And THC Medicare Coverage Plan, Setting Hearing For 4/20
Stay current on Minnesota cannabis
Browse more federal action updates, the full news feed, or the Minnesota cannabis timeline. Compare products across licensed dispensaries and read our consumer guides.